Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis

Liver International

Volumn 29, Issue 3, 2009, Pages 375-383

  Xu, Lizhe ^a   Guo, Linsheng ^b   Shen, Zhiwei ^c   Loss, George ^c   Gish, Robert ^d   Wasilenko, Shawn ^e   Mason, Andrew L ^e  

^a UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c OCHSNER CLINIC FOUNDATION   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; GENE PRODUCT; PROTEIN MER115; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; CHROMOSOME 4; CONTROLLED STUDY; ESCHERICHIA COLI; GENE DUPLICATION; GENE SEQUENCE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MYCOPLASMA HOMINIS; NUCLEOTIDE SEQUENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SLOT BLOT HYBRIDIZATION; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 4; DNA PRIMERS; DNA REPEAT EXPANSION; DNA, INTERGENIC; HUMANS; LIVER CIRRHOSIS, BILIARY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC;

EID: 59849099903     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01888.x     Document Type: Article

References (51)

1. Mason A, Nair S. Primary biliary cirrhosis: New thoughts on pathophysiology and treatment. Curr Gastroenterol Rep 2002; 4: 45-51.
2. Xu L, Shen Z, Guo L, et al. Does a betaretrovirus infection trigger primary biliary cirrhosis? Proc Natl Acad Sci USA 2003; 100: 8454-9.
3. Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Familial primary biliary cirrhosis reassessed: A geographically-based population study. J Hepatol 1999; 30: 402-7.
4. Selmi C, Mayo MJ, Bach N, et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: Genetics, epigenetics, and environment. Gastroenterology 2004; 127: 485-92.
5. Donaldson P, Agarwal K, Craggs A, Craig W, James O, Jones D. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48: 397-402.
6. Manns MP, Bremm A, Schneider PM, et al. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis. Gastroenterology 1991; 101: 1367-73.
7. Selmi C, Invernizzi P, Zuin M, Podda M, Gershwin ME. Genetics and geoepidemiology of primary biliary cirrhosis: Following the footprints to disease etiology. Semin Liv Dis 2005; 25: 265-80.
8. Fan L, Tu X, Zhu Y, et al. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005; 20: 249-55.
9. Halmos B, Szalay F, Cserniczky T, et al. Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig Dis Sci 2000; 45: 1091-5.
10. Lakatos LP, Bajnok E, Hegedus D, Toth T, Lakatos P, Szalay F. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 2002; 14: 733-40.
11. Vogel A, Strassburg CP, Manns MP. Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 2002; 35: 126-31.
12. Agarwal K, Jones DE, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32: 538-41.
13. Bittencourt PL, Palacios SA, Farias AQ, et al. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis. J Gastroenterol Hepatol 2003; 18: 1061-6.
14. Fan LY, Tu XQ, Cheng QB, et al. Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 2004; 10: 3056-9.
15. Kanno Y, Rai T, Monoe K, et al. Possible association of cytotoxic T lymphocyte antigen-4 genetic polymorphism with liver damage of primary biliary cirrhosis in Japan. Fukushima J Med Sci 2006; 52: 79-85.
16. Oertelt S, Kenny TP, Selmi C, Invernizzi P, Podda M, Gershwin ME. SNP analysis of genes implicated in T cell proliferation in primary biliary cirrhosis. Clin Dev Immunol 2005; 12: 259-63.
17. Graham AM, Dollinger MM, Howie SE, Harrison DJ. Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: Analysis of allele frequencies in primary biliary cirrhosis [letter]. J Med Genet 2000; 37: 150-2.
18. Gordon MA, Oppenheim E, Camp NJ, Di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol 1999; 31: 242-7.
19. Matsushita M, Miyakawa H, Tanaka A, et al. Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis. J Autoimmun 2001; 17: 251-7.
20. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDs-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
21. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the difference between two complex genomes. Science 1993; 259: 946-51.
22. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241: 92-7.
23. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavi-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995; 92: 3401-5.
24. Lisitsyn NA. Representational difference analysis: Finding the differences between genomes. Trends Genet 1995; 11: 303-7.
25. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
26. Kamal M, Xie X, Lander ES. A large family of ancient repeat elements in the human genome is under strong selection. Proc Natl Acad Sci USA 2006; 103: 2740-5.
27. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-10.
28. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP. Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 1998; 27: 1736-42.
29. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-17.
30. Cohen JC. Methylation of milk-borne and genetically transmitted mouse mammary tumor virus proviral DNA. Cell 1980; 19: 653-62.
31. Antony J, Van-Marle G, Opii W, et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004; 7: 1021-3.
32. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Ann Neurol 2001; 50: 434-42.
33. Britten R. Transposable elements have contributed to thousands of human proteins. Proc Natl Acad Sci USA 2006; 103: 1798-803.
34. Piriyapongsa J, Marino-Ramirez L, Jordan IK. Origin and evolution of human microRNAs from transposable elements. Genetics 2007; 176: 1323-37.
35. Stewart CA, Horton R, Allcock RJ, et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res 2004; 14: 1176-87.
36. http://microrna.sanger.ac.uk/sequences/search.shtml
37. Notghi A, Nestle U, Rittner G, et al. Chromosomal aberrations in patients with primary biliary cirrhosis. Hum Genet 1990; 85: 546-50.
38. Corpechot C, Barbu V, Chazouilleres O, Poupon R. Fetal microchimerism in primary biliary cirrhosis. J Hepatol 2000; 33: 696-700.
39. Davies JL, Kawaguchi Y, Bennett ST, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-6.
40. Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851-62.
41. Hom G, Graham RR, Modrek B, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008; 358: 900-9.
42. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004; 36: 471-5.
43. Rioux JD, Silverberg MS, Daly MJ, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-70.
44. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006; 444: 444-54.
45. Aitman TJ, Dong R, Vyse TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 2006; 439: 851-5.
46. Fanciulli M, Norsworthy PJ, Petretto E, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet 2007; 39: 721-3.
47. Yang Y, Chung EK, Wu YL, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): Low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 2007; 80: 1037-54.
48. Mckinney C, Merriman ME, Chapman PT, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008; 67: 409-13.
49. Boe Wolff AS, Oftedal B, Johansson S, et al. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): Partial gene deletions contribute to APS I. Genes Immun 2008; 9: 130-6.
50. Relman DA. The search for unrecognized pathogens. Science 1999; 284: 1308-10.
51. Mason A, Doucette K, Wong GK-S. Metagenomics and the case of the deadly hamster. Hepatology 2008; 48: 679-83.